Petros Pharmaceuticals, Inc.
Petros Pharmaceuticals, Inc. (PTPI) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 18 transactions totaling $4.9M, demonstrating a bullish sentiment with $4.9M in net insider flow. The most recent transaction on Jan 2, 2026 involved a transaction of 500,000 shares valued at $0.
PTPI Insider Activity Summary
Who Is Buying PTPI Stock?
No significant insider buying has been recorded for PTPI in the recent period.
Who Is Selling PTPI Stock?
No significant insider selling has been recorded for PTPI in the recent period.
Is Petros Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PTPI is bullish with an Insider Alignment Score of 100/100 and a net flow of $4.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
PTPI Frequently Asked Questions
Understanding PTPI Insider Activity
Insider trading at Petros Pharmaceuticals, Inc. (PTPI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading PTPI stock, having executed 18 transactions in the past 90 days. The most active insider is John D. Shulman (Executive), who has made 2 transactions totaling $2.9M.
Related Tools
Track Petros Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at PTPI file new Form 4 transactions